Skip to main content
Log in

The incidence of human immunodeficiency virus (HIV) in fetal cord samples utilized as serum supplements for in vitro fertilization

  • Short Communication
  • Published:
Journal of in Vitro Fertilization and Embryo Transfer Aims and scope Submit manuscript

Abstract

Prior to initiating routine fetal cord serum (FCS) supplementation in our in vitro laboratory, the incidence of HIV in 306 random fetal cord samples obtained at the Labor and Delivery Unit of the Johns Hopkins Hospital from July 1985 to January 1988 was determined from a crosssectional patient sample. Of 306 samples, 3 (0.98%) were positive for HIV, and confirmed by Western blot analysis, enzyme immunoassay (ELISA), a prevalence significantly higher than a national sample (0.012%). The use of FCS in this setting was determined to be an unacceptable risk to patients undergoing in vitro fertilization. The 90-day quarantine period for verification of HIV seronegativity applied to semen donors may not be applicable to FCS sampling. Patient risk may also increase with pooling of FCS samples prior to HIV testing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Feichtinger W, Kemeter P, Menezo Y: The use of synthetic culture medium and patient serum for human in vitro fertilization and embryo replacement. J Vitro Fert Embryo Transfer 1986;3:87–92

    Google Scholar 

  2. Ogawa T, Marrs RP: The effect of protein supplementation on single-cell mouse embryos in vitro. Fertil Steril 1987; 47:156–161

    Google Scholar 

  3. Benadiva CA, Kuczynski-Brown B, Maguire TG, Mastroianni L Jr, Flickinger GL: Bovine serum albumin (BSA) can replace patient serum as a protein source in an in vitro fertilization (IVF) program. J Vitro Fert Embryo Transfer 1989;6:164–167

    Google Scholar 

  4. Groopman JE, Chen FW, Hope JA, et al.: Serological characterization of HIV infection in AIDS and related disorders. J Infect Dis 1986;153:736–742

    Google Scholar 

  5. Sarngadharan MG, Popovic M, Bruch LO, Schupbach J, Gallo RC: Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science 1984;224:506–508

    Google Scholar 

  6. Tsang VCW, Peralta JM, Simons AR: Enzyme-linked immunoglectrotransfer blot techniques (EITB) for studying the specificities of antigens and antibodies separated by gel electrophoresis. Methods Enzymol 1983;92:377–391

    Google Scholar 

  7. United States Morbidity and Mortality Weekly Report 36, 1987

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Damewood, M.D., Hesla, J.S., Schlaff, W.D. et al. The incidence of human immunodeficiency virus (HIV) in fetal cord samples utilized as serum supplements for in vitro fertilization. J Assist Reprod Genet 7, 365–366 (1990). https://doi.org/10.1007/BF01130593

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01130593

Key words

Navigation